Erasmus MC Transplant Institute
- Research works
- 46 fractional, all time
- Citations
- 676 14.6 per fractional work
- Top-10% rate
- 25.5% record average 16.5%
- Open access
- 89% world 28%
Not ranked overall: Erasmus MC Transplant Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Erasmus MC Transplant Institute specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.4× the share of its output that it takes of world research.
- MedicineField · 32.8 works4.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
- Medicine 4.4×
- Immunology and Microbiology 4.1×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Dentistry 0.3×
- Health Professions 0.3×
- Nursing 0.2×
- Business, Management and Accounting 0.2×
- Psychology 0.2×
- Chemistry 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Neuroscience 0.1×
- Physics and Astronomy 0.0×
- Agricultural and Biological Sciences 0.0×
- Social Sciences 0.0×
Which keywords describe research at Erasmus MC Transplant Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Graft Survival, Kidney Transplantation, Liver Transplantation, Immunosuppressive Drugs, Donor Risk Index, Ischemia-Reperfusion Injury, Antibody-Mediated Rejection and Renal Allograft.
- Drug Delivery
- Biogenesis
- Transplant Recipients
- Metabolic Syndrome
- Biomarkers
- SARS-CoV-2
- Organ Donation
- Living Kidney Donors
- Heart Transplant
- Radiofrequency Ablation
- Liver Cancer
- Survival
- Immunosuppressive Therapy
- Management
- Diagnosis
- Hepatocellular Carcinoma
- Renal Allograft
- Ischemia-Reperfusion Injury
- Immunosuppressive Drugs
- Kidney Transplantation
- Graft Survival
- Liver Transplantation
- Donor Risk Index
- Antibody-Mediated Rejection
- Transplantation
- Treatment
- Epidemiology
- Clinical Practice Guidelines
- Ethical Considerations
- Hepatic Encephalopathy
- Liver Cirrhosis
- Rejection
- Inflammation
- Lung Transplant
- Cancer
- Antiviral Therapy
- Immune Response
- Pandemic
- ACE2 Receptor
- Cholangiocarcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Graft Survival9▲ 300×3 topics
- Kidney Transplantation6▲ 271×2 topics
- Liver Transplantation5▲ 107×4 topics
- Immunosuppressive Drugs5▲ 203×2 topics
- Donor Risk Index5▲ 285×1 topic
- Ischemia-Reperfusion Injury5▲ 183×1 topic
- Antibody-Mediated Rejection4▲ 320×1 topic
- Renal Allograft4▲ 320×1 topic
- Transplantation4▲ 110×4 topics
- Hepatocellular Carcinoma3▲ 37×3 topics
- Treatment3▲ 6.2×6 topics
- Diagnosis3▲ 7.1×6 topics
- Epidemiology2▲ 1.66×14 topics
- Management2▲ 7.9×4 topics
- Clinical Practice Guidelines2▲ 11×5 topics
- Immunosuppressive Therapy2▲ 32×3 topics
- Ethical Considerations2▲ 17×3 topics
- Survival2▲ 40×2 topics
- Hepatic Encephalopathy2▲ 98×1 topic
- Liver Cancer2▲ 94×1 topic
- Liver Cirrhosis2▲ 98×1 topic
- Radiofrequency Ablation2▲ 50×1 topic
- Rejection2▲ 129×2 topics
- Heart Transplant2▲ 151×1 topic
- Inflammation2▲ 2.4×13 topics
- Living Kidney Donors2▲ 201×1 topic
- Lung Transplant2▲ 151×1 topic
- Organ Donation2▲ 201×1 topic
- Cancer1▲ 2.7×7 topics
- SARS-CoV-21▲ 11×3 topics
- Antiviral Therapy1▲ 35×3 topics
- Biomarkers1▲ 5.0×5 topics
- Immune Response1▲ 6.1×8 topics
- Metabolic Syndrome1▲ 4.3×5 topics
- Pandemic1▲ 2.8×3 topics
- Transplant Recipients1▲ 55×2 topics
- ACE2 Receptor1▲ 12×2 topics
- Biogenesis1▲ 15×2 topics
- Cholangiocarcinoma1▲ 37×2 topics
- Drug Delivery1▲ 5.0×2 topics
Which research topics does Erasmus MC Transplant Institute publish most on?
By volume in 2022–2025: Organ Transplantation Techniques and Outcomes, Renal Transplantation Outcomes and Treatments, Hepatocellular Carcinoma Treatment and Prognosis and Liver Disease and Transplantation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Organ Transplantation Techniques and Outcomes Surgery 5 works
- 2 Renal Transplantation Outcomes and Treatments Transplantation 4 works
- 3 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
- 4 Liver Disease and Transplantation Hepatology 2 works
- 5 Transplantation: Methods and Outcomes Surgery 2 works
- 6 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 2 works
- 7 Extracellular vesicles in disease Molecular Biology 1 works
- 8 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 9 Cytomegalovirus and herpesvirus research Epidemiology 1 works
- 10 T-cell and B-cell Immunology Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Erasmus MC Transplant Institute's research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rotterdam
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.